Abstract

Eupalinolide A (EA, Z-configuration) and Eupalinolide B (EB, E-configuration) are cis-trans isomeric sesquiterpenoid monomers isolated from Eupatorium lindleyanum DC. (Asteraceae). Although these compounds display anti-inflammatory and anti-tumor activities, their metabolite profiles and possible hepatotoxicity remain largely unknown. This study aimed to investigate the metabolic profiles of EA and EB in liver microsomes and clarify whether they undergo metabolic activation or detoxification. EA and EB were metabolically profiled in human liver microsomes (HLMs) via UPLC-Q-TOF-MS. A HepG2-HLM co-culture system was used to compare the hepatocyte toxicity of parent compounds and their hydrolysis, oxidation, and hydrolysis–oxidation metabolites, thus evaluating their metabolic detoxification pathways. Sixteen metabolites of EA and 19 of EB were identified, with hydrolysis being the predominant metabolic pathway for both isomers. Both compounds showed low hepatocyte toxicity and underwent metabolic detoxification mainly via hydrolytic and oxidative pathways. Notably, hydrolysis metabolites had significantly lower toxicity than oxidative products in HepG2 cells. These results suggest that EA and EB could present a relatively low risk of in vivo hepatotoxicity, which provides useful information for understanding the metabolic behavior and safety profile of these bioactive sesquiterpenoids.

By Yingzi Li, Xiaoyan Liu, Ludi Li, Wusheng Xiao, Youbo Zhang, Kewu Zeng and Qi Wang